 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| . |  |
. |
Novartis denies problems with swine flu vaccine
Geneva (AFP) Oct 26, 2009 Swiss pharmaceutical group Novartis on Monday denied that it faced hurdles in gaining regulatory approval in Switzerland for one of its swine flu vaccines because of possible bacterial contamination. The vaccine, branded as Celtura, is produced by a technique using cell cultures from dog kidneys, allowing more rapid production than by the more classical method using chicken eggs, according to the company. Citing anonymous sources close to the case, the Swiss daily Tages-Anzeiger reported on Saturday that the Swiss authority overseeing medicines and therapeutical products, Swissmedic, had found bacterial contamination in test batches of Celtura. A spokesman at Swissmedic told AFP that the agency could "neither confirm nor deny" the report. Swissmedic is due to give its authorisation for the vaccine this week ahead of a mass vaccination campaign against influenza A(H1N1) in Switzerland. A spokesman for Novartis, Eric Althoff, insisted on Monday that the Celtura vaccine was not contaminated. "There is no contamination of Celtura, the process is much cleaner than by chicken eggs," he told AFP. Novartis is hoping for the green light to market the vaccine from Swiss health authorities in the coming days and from the European Union in the next few weeks. The spokesman insisted that the production process was the same as that which has been used on a seasonal flu vaccine for several years. About 8,000 people have taken part in clinical trials of A(H1N1) vaccines, he added. Novartis already markets another swine flu vaccine in Europe under the brand name Focetria, which is based on chicken egg cultures. Share This Article With Planet Earth
Related Links Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola
More than half of Chinese don't want swine flu shot: pollBeijing (AFP) Oct 26, 2009 More than half of all Chinese do not plan to be vaccinated against swine flu because they are unsure about the safety of the shot, according to a survey by state media published Monday. The poll by the China Daily and popular web portal sohu.com said more than 54 percent of the 2,000 respondents said they did not want the A(H1N1) vaccine -- a huge turnaround from two months ago, when 76 ... read more |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2009 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |
del.icio.us
Digg
Reddit
YahooMyWeb
Google
Facebook